131 related articles for article (PubMed ID: 3252078)
21. In vitro antibacterial activity of aztreonam against gram-negative bacilli isolated in 1985.
Miyake Y; Yokoyama T; Nakano H; Kuwabara M; Yamakido M; Suginaka H
Hiroshima J Med Sci; 1988 Sep; 37(3):115-7. PubMed ID: 3248945
[No Abstract] [Full Text] [Related]
22. Surgery-related infections: a challenge for the physician. Introduction.
Nichols RL
Surg Gynecol Obstet; 1990; 171 Suppl():9-10. PubMed ID: 2244296
[No Abstract] [Full Text] [Related]
23. Efficacy and safety of aztreonam versus tobramycin for aerobic gram-negative bacilli lower respiratory tract infections.
Rodriguez JR; Ramirez-Ronda CH
Am J Med; 1985 Feb; 78(2A):42-3. PubMed ID: 4038578
[TBL] [Abstract][Full Text] [Related]
24. Aztreonam in the treatment of serious gram-negative infections in the elderly.
Deger F; Douchamps J; Freschi E; Thys JP; Nève P; Herchuelz A
Int J Clin Pharmacol Ther Toxicol; 1988 Jan; 26(1):22-6. PubMed ID: 3403089
[TBL] [Abstract][Full Text] [Related]
25. Aztreonam therapy for complicated urinary tract infections caused by multidrug-resistant bacteria.
Cox CE
Rev Infect Dis; 1985; 7 Suppl 4():S767-71. PubMed ID: 3909335
[TBL] [Abstract][Full Text] [Related]
26. In vitro and in vivo experience with carumonam: a preliminary report.
Kanellakopoulou K; Manta M; Tsagaraki C; Giamarellou H
J Chemother; 1989 Jul; 1(4 Suppl):125. PubMed ID: 16312334
[No Abstract] [Full Text] [Related]
27. [Suppurative septic infection].
Chuev PN; Lukich VL; Dotsenko AP; Korotaev GM
Sov Med; 1987; (4):57-61. PubMed ID: 3299741
[No Abstract] [Full Text] [Related]
28. Clinical evaluation of aztreonam for serious gram-negative bacterial infections.
Raz R; Flatau E; Sudarsky M; Keness J
Chemioterapia; 1988 Feb; 7(1):42-5. PubMed ID: 3378275
[TBL] [Abstract][Full Text] [Related]
29. The identity and in vitro antibiotic sensitivity of aerobic gram-negative rods in a community hospital.
Ellenbogen C; Hester SC
N C Med J; 1984 Jan; 45(1):19-22. PubMed ID: 6583511
[No Abstract] [Full Text] [Related]
30. Aztreonam in the treatment of gram-negative meningitis in children.
Isani Z; Rehman N; Adil N; el Messidi M
Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
[No Abstract] [Full Text] [Related]
31. Gram-negative aerobic bacterial infections: a focus on directed therapy, with special reference to aztreonam.
Rev Infect Dis; 1985; 7 Suppl 4():S537-843. PubMed ID: 4081472
[No Abstract] [Full Text] [Related]
32. R-factors in gram-positive and gram-negative aerobic bacteria selected by antimicrobial therapy.
Buu-Hoi A; Goldstein FW; Acar JF
Scand J Infect Dis Suppl; 1986; 49():46-55. PubMed ID: 3547625
[TBL] [Abstract][Full Text] [Related]
33. [Clinical review and antibacterial effect of aztreonam in infections in obstetrics and gynecology].
Fujimoto S; Makinoda S; Tanaka T; Ichinohe K
Jpn J Antibiot; 1985 Dec; 38(12):3513-9. PubMed ID: 3841730
[TBL] [Abstract][Full Text] [Related]
34. Comparative in-vitro antibacterial activity of aztreonam against clinical isolates of gram-negative bacteria.
Shibl AM; Ishag AH; Durgham SM
J Chemother; 1989 Jul; 1(4 Suppl):359-61. PubMed ID: 16312439
[No Abstract] [Full Text] [Related]
35. In vitro activity of Ro 17-2301, a new monobactam, against gram-negative bacteria resistant to aminoglycosides.
Landinez R; Garcia M; Merino C
Chemioterapia; 1987 Jun; 6(2 Suppl):112-4. PubMed ID: 3509365
[No Abstract] [Full Text] [Related]
36. Emerging resistance of non-fermenting gram negative bacilli in a tertiary care centre.
Samanta P; Gautam V; Thapar R; Ray P
Indian J Pathol Microbiol; 2011; 54(3):666-7. PubMed ID: 21934266
[No Abstract] [Full Text] [Related]
37. Aztreonam in the treatment of soft tissue infections including diabetic foot infections.
Torres A; Ramírez-Ronda CH
Bol Asoc Med P R; 1985 May; 77(5):191-4. PubMed ID: 3860207
[No Abstract] [Full Text] [Related]
38. In vitro susceptibilities of common gram negative bacilli to aminoglycosides and cephalosporins.
Patamasucon P; Kalnauwakul S; Ratamaruesa A; Silpapojakul K
J Med Assoc Thai; 1987 Sep; 70(9):511-5. PubMed ID: 3681179
[No Abstract] [Full Text] [Related]
39. Aztreonam plus clindamycin as therapy for pelvic infections in women.
Pastorek JG; Cole C; Aldridge KE; Crapanzano JC
Am J Med; 1985 Feb; 78(2A):47-50. PubMed ID: 4038579
[TBL] [Abstract][Full Text] [Related]
40. The susceptibility of bacteroides, fusobacterium leptotrichia, and sphaerophorus strains to rifampicin.
Werner H
Arzneimittelforschung; 1972 Jun; 22(6):1043-5. PubMed ID: 5068353
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
